Last updated on June 2019

Korean Post-marketing Surveillance for Xeljanz

Brief description of study

The objective of this study is to identify any problems and questions with respect to the safety and efficacy of Xeljanz during the post-marketing period as required by the regulation of MFDS.

Clinical Study Identifier: NCT02984020

Find a site near you

Start Over

Jeju National University Hospital

Jeju Special Self-Goverming Province, Korea, Republic of
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.